Aspen Pharmacare Holdings Limited

Johannesburg Stock Exchange:APN.JO

Sector

🏥 Health Care

Industries

💊 Pharmaceuticals

🔬 Clinical Trials

💊 Drugstores & Retail Pharmacies

🛍 Specialty Retail

Location

South Africa

Market Cap

USD 2.93 B

Share Price

USD 6.58

Avg Daily Volume

2,211,997

Change (1 day)

-1.12%

Change (1 year)

-45.14%

Change (YTD)

-24.66%

Aspen Pharmacare Holdings Limited Net Cash Used For Investing Activities for the year ending June 30, 2024: USD -520.86 M

Aspen Pharmacare Holdings Limited Net Cash Used For Investing Activities is USD -520.86 M for the year ending June 30, 2024, a 187.82% change year over year. Net cash used for investing activities is total cash inflows and outflows related to activities intended to generate future income and cash flows from investments.

Aspen Pharmacare Holdings Limited Net Cash Used For Investing Activities for the year ending June 30, 2023 was USD -180.97 M, a 37.29% change year over year.
Aspen Pharmacare Holdings Limited Net Cash Used For Investing Activities for the year ending June 30, 2022 was USD -131.82 M, a -119.40% change year over year.
Aspen Pharmacare Holdings Limited Net Cash Used For Investing Activities for the year ending June 30, 2021 was USD 679.50 M, a 631.49% change year over year.
Aspen Pharmacare Holdings Limited Net Cash Used For Investing Activities for the year ending June 30, 2020 was USD 92.89 M, a -59.36% change year over year.

Quarterly
Annual
TTM

From:

To:

Zoom:

Key data

Date	Net Cash Used For Investing Activities	Net Cash Used Provided By Financing Activities	Depreciation And Amortization	Dividends Paid

Johannesburg Stock Exchange: APN.JO

Aspen Pharmacare Holdings Limited

CEO	Mr. Stephen Bradley Saad BCom, CA(SA)
IPO Date	Jan. 4, 2000
Location	South Africa
Headquarters	Aspen Place
Employees	8,867
Sector	🏥 Health Care
Industries Pharmaceuticals 🔬 Clinical Trials 💊 Drugstores & Retail Pharmacies 🛍 Specialty Retail

Description

Aspen Pharmacare Holdings Limited, together with its subsidiaries, manufactures and supplies specialty and branded pharmaceutical products worldwide. It operates in Commercial Pharmaceuticals and Manufacturing segments. The company provides general anesthetics, muscle relaxants, and topical agents under the Anaesthetics brand; and a range of injectable anticoagulants with a focus on low molecular weight heparins, Xa inhibitors, and heparin derivatives under the Thrombosis brand. It also offers branded consumer, prescription, and over-the-counter products under the regional brands, such as Circadin, Foxair, Maltofer, Mybulen, and Zyloric for various types of anesthetic comprises sleeping aid, respiratory, iron supplement, analgesic, and uric acid production inhibitor. In addition, the company manufactures and sells active pharmaceutical ingredients and finished dose form products to third-party customers. The company was founded in 1850 and is headquartered in Durban, South Africa.